These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 14760953)
1. The patient's perception of a (reliable) change in the Multiple Sclerosis Functional Composite. Hoogervorst EL; Kalkers NF; Cutter GR; Uitdehaag BM; Polman CH Mult Scler; 2004 Feb; 10(1):55-60. PubMed ID: 14760953 [TBL] [Abstract][Full Text] [Related]
2. Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability. Hoogervorst EL; Zwemmer JN; Jelles B; Polman CH; Uitdehaag BM Mult Scler; 2004 Oct; 10(5):569-74. PubMed ID: 15471375 [TBL] [Abstract][Full Text] [Related]
3. One year changes in disability in multiple sclerosis: neurological examination compared with patient self report. Hoogervorst EL; Eikelenboom MJ; Uitdehaag BM; Polman CH J Neurol Neurosurg Psychiatry; 2003 Apr; 74(4):439-42. PubMed ID: 12640058 [TBL] [Abstract][Full Text] [Related]
4. Comparisons of patient self-report, neurologic examination, and functional impairment in MS. Hoogervorst EL; van Winsen LM; Eikelenboom MJ; Kalkers NF; Uitdehaag BM; Polman CH Neurology; 2001 Apr; 56(7):934-7. PubMed ID: 11294932 [TBL] [Abstract][Full Text] [Related]
5. How similar are commonly combined criteria for EDSS progression in multiple sclerosis? Kragt JJ; Nielsen IM; van der Linden FA; Uitdehaag BM; Polman CH Mult Scler; 2006 Dec; 12(6):782-6. PubMed ID: 17263007 [TBL] [Abstract][Full Text] [Related]
6. A study validating changes in the multiple sclerosis functional composite. Hoogervorst EL; Kalkers NF; Uitdehaag BM; Polman CH Arch Neurol; 2002 Jan; 59(1):113-6. PubMed ID: 11790238 [TBL] [Abstract][Full Text] [Related]
7. The Guy's Neurological Disability Scale in patients with multiple sclerosis: a clinical evaluation of its reliability and validity. Rossier P; Wade DT Clin Rehabil; 2002 Feb; 16(1):75-95. PubMed ID: 11837529 [TBL] [Abstract][Full Text] [Related]
8. Differential treatment effect on measures of neurologic exam, functional impairment and patient self-report in multiple sclerosis. Hoogervorst EL; Kalkers NF; van Winsen LML ; Uitdehaag BM; Polman CH Mult Scler; 2001 Oct; 7(5):335-9. PubMed ID: 11724450 [TBL] [Abstract][Full Text] [Related]
9. Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis. Ozakbas S; Cagiran I; Ormeci B; Idiman E J Neurol Sci; 2004 Mar; 218(1-2):3-7. PubMed ID: 14759626 [TBL] [Abstract][Full Text] [Related]
10. Utilization of the multiple sclerosis functional composite in follow-up: relationship to disease phenotype, disability and treatment strategies. Ozakbas S; Ormeci B; Idiman E J Neurol Sci; 2005 May; 232(1-2):65-9. PubMed ID: 15850584 [TBL] [Abstract][Full Text] [Related]
11. The longitudinal relationship between the patient-reported Multiple Sclerosis Impact Scale and the clinician-assessed Multiple Sclerosis Functional Composite. Costelloe L; O'Rourke K; McGuigan C; Walsh C; Tubridy N; Hutchinson M Mult Scler; 2008 Mar; 14(2):255-8. PubMed ID: 17942522 [TBL] [Abstract][Full Text] [Related]
12. Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test. Drake AS; Weinstock-Guttman B; Morrow SA; Hojnacki D; Munschauer FE; Benedict RH Mult Scler; 2010 Feb; 16(2):228-37. PubMed ID: 20028710 [TBL] [Abstract][Full Text] [Related]
13. Clinical impact of 20% worsening on Timed 25-foot Walk and 9-hole Peg Test in multiple sclerosis. Kragt JJ; van der Linden FA; Nielsen JM; Uitdehaag BM; Polman CH Mult Scler; 2006 Oct; 12(5):594-8. PubMed ID: 17086905 [TBL] [Abstract][Full Text] [Related]
14. Psychometric properties of the Italian version of the Guy's Neurological Disability Scale. Pappalardo A; Patti F Funct Neurol; 2010; 25(4):223-33. PubMed ID: 21388584 [TBL] [Abstract][Full Text] [Related]
15. Factor structure of Guy's Neurological Disability Scale in a sample of Dutch patients with multiple sclerosis. Mokkink LB; Knol DL; Uitdehaag BM Mult Scler; 2011 Dec; 17(12):1498-503. PubMed ID: 21828196 [TBL] [Abstract][Full Text] [Related]
16. Psychometric testing of the Americanized version of the Guy's Neurological Disability Scale. Fraser C; McGurl J J Neurosci Nurs; 2007 Feb; 39(1):13-9. PubMed ID: 17396533 [TBL] [Abstract][Full Text] [Related]
17. The INTERMED: a screening instrument to identify multiple sclerosis patients in need of multidisciplinary treatment. Hoogervorst EL; de Jonge P; Jelles B; Huyse FJ; Heeres I; van der Ploeg HM; Uitdehaag BM; Polman CH J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):20-4. PubMed ID: 12486260 [TBL] [Abstract][Full Text] [Related]
18. Validation of the Guy's Neurological Disability Scale as a screening tool for cognitive impairment in multiple sclerosis. Akatani R; Chihara N; Tachibana H; Koto S; Kowa H; Kanda F; Matsumoto R; Toda T Mult Scler Relat Disord; 2019 Oct; 35():272-275. PubMed ID: 31442905 [TBL] [Abstract][Full Text] [Related]
19. The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis. Sharrack B; Hughes RA Mult Scler; 1999 Aug; 5(4):223-33. PubMed ID: 10467380 [TBL] [Abstract][Full Text] [Related]
20. Responsiveness and predictive value of EDSS and MSFC in primary progressive MS. Kragt JJ; Thompson AJ; Montalban X; Tintoré M; Río J; Polman CH; Uitdehaag BM Neurology; 2008 Mar; 70(13 Pt 2):1084-91. PubMed ID: 18184917 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]